Skip to content
value.today

EnteroBiotix LTD

Total raised
$18 M
2 rounds on record
Latest round
$7 M
Aug 2023
First round on record
Aug 2022
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of EnteroBiotix LTD
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2023$7 MNo. 2$2 to $10 million

EnteroBiotix LTD: Raise no. 2, Aug 2023

Investors in this round

3 investors had bought by the notice of Aug 14, 2023: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M (amount offered: indefinite)
Smallest investment taken
$127,562
What was sold
debt, options or other rights to buy securities, other: debt convertible into equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in United Kingdom

People named in the notice

  • James McIlroy · Executive Officer, Director
  • David Lawrence · Director
  • Douglas Thomson · Director
  • Elmar Schnee · Director
  • Iain Baird · Director
  • Mark Bamforth · Director, Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Issue is denominated in GBP to the nearest $1. All amounts have been converted from GBP to USD at the rate of 1 GBP = 1.2757 USD (August 4, 2023)”

Signed by James R. McIlroy, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 14, 2023. Read the notice at the SEC.

debt, optionsSEC
Aug 2022$11 MNo. 1$10 to $50 million

EnteroBiotix LTD: Raise no. 1, Aug 2022

Investors in this round

5 investors had bought by the notice of Sep 14, 2022: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $13 M offered; $2 M still to sell
Smallest investment taken
$117,000
What was sold
debt, options or other rights to buy securities, other: debt convertible into equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in United Kingdom

People named in the notice

  • James Roger McIlroy · Executive Officer, Director, Promoter
  • David Muir Lawrence · Director
  • Douglas Campbell Thomson · Director
  • Iain J. Baird · Director
  • Mark R. Bamforth · Director, Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Issue is denominated in GBP to the nearest $1,000. All amounts have been converted from GBP to USD at the rate of 1 GBP = 1.170227 USD (September 12, 2022)”

Signed by James R. McIlroy, Chief Executive Officer. Source: SEC Form D, newest notice filed Sep 14, 2022. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • EnteroBiotix LTD chose not to state its revenue in its newest notice of a funding round (Aug 2023).

    SEC Form D · Aug 2023

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Aug 2023

That is all the official record says: EnteroBiotix LTD has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of EnteroBiotix LTD is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 5 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by EnteroBiotix LTD
NameRoleNamed in
James McIlroyExecutive officerAug 2023
James Roger McIlroyExecutive officerSep 2022
David LawrenceDirectorAug 2023
Douglas ThomsonDirectorAug 2023
Elmar SchneeDirectorAug 2023
Iain BairdDirectorAug 2023
James McIlroyDirectorAug 2023
Mark BamforthDirectorAug 2023
David Muir LawrenceDirectorSep 2022
Douglas Campbell ThomsonDirectorSep 2022
Iain J. BairdDirectorSep 2022
James Roger McIlroyDirectorSep 2022
Mark R. BamforthDirectorSep 2022
Mark BamforthPromoterAug 2023
James Roger McIlroyPromoterSep 2022
Mark R. BamforthPromoterSep 2022